Nova Patents
AT513847T

Bioactive peptides

Abstract

(57) Amino acid of the oleophilicity invention / summary book] in one piece or the 嵩 quantity of non-heredity beyond it, And 7 which has a cationic 残 machine which has the ester, amide, salt, and its circular derivative one piece or more or the amount body cell toxicity peptide of 25, And the use as an anti-microbe agent or an anti-tumor agent is offered especially as the production method of such peptide, the medicine composites containing them, and those medicines.

Term

Term ended

Expired 31 August 2019, 7.1 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

67 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
9818938United KingdomA
9902851United KingdomW

Members67

Family members, oldest first
DocumentOfficeKind
GB9818938D0United KingdomD0
CA2340326A1CanadaA1
CA2341037A1CanadaA1
WO0012541A2World Intellectual Property Organization (WIPO)A2
WO0012542A2World Intellectual Property Organization (WIPO)A2
AU5526799AAustraliaA
AU5526899AAustraliaA
GB0005702D0United KingdomD0
WO0012541A3World Intellectual Property Organization (WIPO)A3
WO0012542A3World Intellectual Property Organization (WIPO)A3
NO20010995D0NorwayD0
CA2382544A1CanadaA1
WO0119852A2World Intellectual Property Organization (WIPO)A2
AU6858700AAustraliaA
NO20010995LNorwayL
EP1109827A2European Patent Office (EPO)A2
EP1109831A2European Patent Office (EPO)A2
NO20020950D0NorwayD0
NO20020950LNorwayL
JP2002523517AJapanA
WO0119852A3World Intellectual Property Organization (WIPO)A3
EP1259536A2European Patent Office (EPO)A2
US2003022821A1United States of AmericaA1
JP2003516931AJapanA
US2003148936A1United States of AmericaA1
AU772176B2AustraliaB2
WO0119852A8World Intellectual Property Organization (WIPO)A8
US6890902B2United States of AmericaB2
AU781243B2AustraliaB2
GB0605685D0United KingdomD0
AU2007228574A1AustraliaA1
CA2646589A1CanadaA1
WO2007107748A2World Intellectual Property Organization (WIPO)A2
WO2007107748A3World Intellectual Property Organization (WIPO)A3
US2008019993A1United States of AmericaA1
US7393824B1United States of AmericaB1
US7439228B2United States of AmericaB2
US2008287346A1United States of AmericaA1
NO20084053LNorwayL
EP2010204A2European Patent Office (EPO)A2
EP1259536B1European Patent Office (EPO)B1
AT422502TAustriaT
DE60041556D1GermanyD1
PT1259536EPortugalE
DK1259536T3DenmarkT3
ES2322228T3SpainT3
CN101466391AChinaA
JP2009530359AJapanA
EP1109831B1European Patent Office (EPO)B1
AT495192TAustriaT
DE69943130D1GermanyD1
NO330170B1NorwayB1
DK1109831T3DenmarkT3
ES2359616T3SpainT3
EP1109827B1European Patent Office (EPO)B1
AT513847TThis recordAustriaT
JP4902919B2JapanB2
US8143211B2United States of AmericaB2
US8283315B2United States of AmericaB2
NO333073B1NorwayB1
AU2007228574B2AustraliaB2
CA2341037CCanadaC
US2014037657A1United States of AmericaA1
JP5475937B2JapanB2
CY1109450T1CyprusT1
US9109048B2United States of AmericaB2
CA2646589CCanadaC